top of page
Cardiovascular & ECG Core Laboratory
Clinical Cardiovascular Research Center
CENTER FOR CLINICAL EVALUATION OF EMERGING POINT-OF-CARE TECHNOLOGIES (CLEOPE)
WHAT IS CLEOPE?
​
The mission of the CENTER FOR CLINICAL EVALUATION OF EMERGING POINT-OF-CARE TECHNOLOGIES (CLEOPE) is to facilitate the validation of novel point-of-care monitoring and diagnostic technologies for clinical practices by integrating medical, technical, clinical, and economic resources and expertise into a comprehensive set of services to academic and industry stakeholders.
WHY CLEOPE ?
Significant growth in elderly populations, coupled with a rising prevalence of chronic diseases, has caused the healthcare systems in the U.S., Europe, and Asia to undergo a strategic change in focus by moving from diagnosis to prevention for various chronic disease states. This, in turn, has stimulated the growth and development of technologies for home care, remote monitoring, telehealth, and self-monitoring. Devices worn on or close to the body are expected to produce the most ground-breaking of these innovations. These “Emerging Health Technologies” lower the usability constraints and increase the monitoring frequency and duration, facilitate diagnostic testing; hence, delivering new insights into disease progression and patient status. As an example, the market for wearable technologies is predicted to reach up to $53 billion worldwide, with 25-35 percent annual growth within the next three years.
​
CLEOPE is designed to help oganizations to streamline the validation of eHealth technologies by faciliating access to resources such as: clinical study design, statsitics, patients access, clinical experience, support for submission to Federal funding programs, a large portfolio of scientfic experts and researchers.
CLEOPE is organized in four components:
The novel POC technologies also referred as Point-of-Care technologies have gained a significant momentum in federal agencies and international scientific societies such as the NIH and the IEEE society which combined forces to facilitate translational research around point of care.
​
The CCRC has been intervening in such National meeting to share their experience in developing these technologies under federal fundings including R01, STTR and SBIR-partnership programs. During these interactions, the stakeholders from the academia and industry commonly agreed on the need to develop a tool facilitating the access to clinical resources needed for the validation/verification of POCT. Interestingly, this path has not been unformely formalized and current stakeholders relies on multiple and expensive collaborative efforts to assemble all required components.
​
CLEOPE is desigend to facilitate the developent of such collaboration. by levraging the mulitple scientfic and logistic resources of the University of Rochester.
​
Enabling
SBIR/STTR
submission
for your
organization
Learn how we can help you submit a successful grant to NIH
Accessing
unique sets of ECG for validation and development of your technologies
Access to the largest open database of fuly-digital ECG in the world.
Developing
targeted
Research
Project
advancing your product lines
University or Rochester , Strong Memorial Hospital and UR Medical Center
delivers the resources needed to conduct state-of-the-art studies.
Facilitating
access to
FDA clearance
and regulated markets
DeNovo, 510(k), pre-CERT submissions .
Select the right path to your technology clearance.
TESTIMONIALS
" For my startup companies, CLEOPE has provided an amazing set of scientific, adminsitrative and logistics support for submitting a multi-million dollar research project to NIH."
Nicholas Conn, CEO, Heart Health Intelligence, Inc., Rochester, NY
" CLEOPE has enabled my company to get more than $1.2 million in federal funding to develop my new line of home monitoring devices. The technical , logistics and scientific supports were exceptional and make my NIH-submission a breather..."
James Demaso, CEO, Global Instrumentations LLC, Syracuse, NY
bottom of page